Czechia vs Latvia: Colon and rectum cancer screening coverage in Europe
Czechia
31.1%
in 2024
Latvia
28.0%
in 2025
Czechia rank
14th
Latvia rank
16th
Colon and rectum cancer screening coverage in Europe over time
- Czechia
- Latvia
How they compare
Czechia currently reports 31.1% against 28.0% in Latvia, a difference of 3.1%.
That makes Czechia's figure about 1.1 times Latvia's.
Across all 14 years both countries report, Czechia has been ahead every year.
Czechia ranks 14th and Latvia ranks 16th of 20 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Czechia | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.9% | 11.3% | 17.6% | Czechia |
| 2020s | 28.8% | 20.8% | 7.9% | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Czechia or Latvia?
- Czechia, at 31.1% against 28.0% in Latvia as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Czechia and Latvia?
- 3.1%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Latvia?
- 14 years are reported by both, from 2011 to 2024.
- How do Czechia and Latvia rank globally for colon and rectum cancer screening coverage in europe?
- Czechia ranks 14th and Latvia ranks 16th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.